Obama Sides With RIAA, Supports $150,000 Fine per Music Track | Threat Level from Wired.com:
"The Obama administration for the first time is weighing in on a Recording Industry Association of America file sharing lawsuit and is supporting hefty awards of as much as $150,000 per purloined music track. "
All You Need for Fresh Air: 3 Essential Green Plants | greenUPGRADER:
"Seventeen years ago Kamal Meattle found out that the air in his home city of Dehli was killing him. He had grown allergic to the pollutants in the air and his lung capacity started declined to 70%. He began researching and found that these three plants can provide a human with all the fresh air they need indoors to be healthy. The three plants are the Areca Palm, the Mother-in-law’s Tongue , and the Money Plant."
A Medical Madoff: Anesthesiologist Faked Data in 21 Studies: Scientific American:
"Over the past 12 years, anesthesiologist Scott Reuben revolutionized the way physicians provide pain relief to patients undergoing orthopedic surgery for everything from torn ligaments to worn-out hips. Now, the profession is in shambles after an investigation revealed that at least 21 of Reuben's papers were pure fiction, and that the pain drugs he touted in them may have slowed postoperative healing. 'We are talking about millions of patients worldwide, where postoperative pain management has been affected by the research findings of Dr. Reuben,' says Steven Shafer, editor in chief of the journal Anesthesia & Analgesia, which published 10 of Reuben's fraudulent papers. Paul White, another editor at the journal, estimates that Reuben's studies led to the sale of billions of dollars worth of the potentially dangerous drugs known as COX2 inhibitors, Pfizer's Celebrex (celecoxib) and Merck's Vioxx (rofecoxib), for applications whose therapeutic benefits are now in question. Reuben was a member of Pfizer's speaker's bureau and received five independent research grants from the company. The editors do not believe patients were significantly harmed by the short-term use of these COX2 inhibitors for pain management but they say it's possible the therapy may have prolonged recovery periods."
[BOT] New Study Explains How Pot Kills Cancer Cells:
"A new study published in Nature Reviews-Cancer provides an historic and detailed explanation about how THC and natural cannabinoids counteract cancer, but preserve normal cells. The study by Manuel Guzmán of Madrid Spain found that cannabinoids, the active components of marijuana, inhibit tumor growth in laboratory animals. They do so by modulating key cell-signalling pathways, thereby inducing direct growth arrest and death of tumor cells, as well as by inhibiting the growth of blood vessels that supply the tumor. The Guzman study is very important according to Dr. Ethan Russo , a neurologist and world authority on medical cannabis: 'Cancer occurs because cells become immortalized; they fail to heed normal signals to turn off growth. A normal function of remodelling in the body requires that cells die on cue. This is called apoptosis, or programmed cell death. That process fails to work in tumors. THC promotes its reappearance so that gliomas, leukemias, melanomas and other cell types will in fact heed the signals, stop dividing, and die.' 'But, that is not all,' explains Dr. Russo: 'The other way that tumors grow is by ensuring that they are nourished: they send out signals to promote angiogenesis, the growth of new blood vessels. Cannabinoids turn off these signals as well. It is truly incredible, and elegant.' "
"Scientists at the University of California created a neural implant for a beetle that gives them wireless control over the insect. Electrical signals delivered via the electrodes command the insect to take off, turn left or right, or hover in midflight. Beetles and other flying insects are masters of flight control, integrating sensory feedback from the visual system and other senses to navigate and maintain stable flight, all the while using little energy. Rather than trying to re-create these systems from scratch, Michel Maharbiz and his colleagues aim to fuse the ‘born’ with the ‘made’. "
Posts
All Comments
